Thomas C. Thompson was formerly Chairman and CEO of Gulf States Oil and Refining Co. He is a founding member and has served more than 30 years on the Baylor College of Medicine Technologies Board. Mr. Thompson has served on the Board of numerous medical technology companies and has been the managing director of a number of medical technology investment partnerships. He is currently the Chairman of Thompson Energy Group, one of the nation’s largest petroleum products brokerage firms, and Medical Metrics Inc., a medical imaging core lab and leading provider of centralized radiographic reading services to the clinical trials industry. Mr. Thompson was honored with a PhD in Business Administration from Nathaniel Hawthorn College in Antrim, New Hampshire.
Dr. James Lupski, MD, PhD is the Cullen Professor of Molecular and Human Genetics and Professor of Pediatrics. Through studies of Charcot-Marie-Tooth (CMT) peripheral neuropathy and Smith-Magenis syndrome, his laboratory has delineated the concept of ‘genomic disorders’. Recently, the laboratory’s CMT studies in collaborations with Richard Gibbs and the Baylor Human Genome Sequencing Center resulted in the first personal genome sequence to identify a “disease gene” by whole genome sequencing (WGS) and demonstrated the utility of WGS for optimizing patient management. These latter investigations further elucidated the potential role of rare variants in complex traits such as carpal tunnel syndrome and fibromyalgia. Dr. Lupski was awarded a Doctor of Science degree honoris causa in 2011 from the Watson School of Biological Science at the Cold Spring Harbor Laboratory. Dr. Lupski was elected to the Institute of Medicine of the National Academies of Science (2002) and to the American Academy of Arts and Sciences (2013) and recently received the 2014 Environmental Mutagenesis and Genomics Society Award. He has coauthored over 575 scientific publications, is a co-inventor on more than 20 patents regarding molecular diagnostics and has delivered over 453 invited lectures in 35 countries.
Steven D. Arnold, MBA has significant expertise in corporate leadership and investment management. Mr. Arnold is a respected management consultant that has both led and served as a director for a number of companies. Specific to healthcare management, he holds a number of board positions including at Houston Methodist Research Institute, Curing Children’s Cancer Fund and Texas Children’s Hospital Cancer Center.
Mimi Healy, President and CEO of Lasergen, is also a member of the board.